v3.25.1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)
 9 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Operating activities:    
Net income $ 122,000 $ 64,000
Adjustments to reconcile net income to net cash (used in) generated from operating activities:    
Depreciation 0 1,000
Fair value of warrants for services 195,000 0
Gain on patent assignment (880,000) 0
Effect of changes in:    
Accounts receivable (122,000) (19,000)
Operating lease right of use asset 42,000 53,000
Accounts payable and accrued expenses 12,000 133,000
Accrued payroll and payroll taxes – related parties 48,000 0
Advances from distributor, net 0 (9,000)
Operating lease liability (46,000) (56,000)
Prepaid expenses 5,000 (2,000)
Net cash (used in) generated from operating activities (624,000) 165,000
Investing activities:    
Proceeds from patent assignment 880,000 0
Net cash provided by investing activities 880,000 0
Financing activities:    
Repayment of note payable (3,000) 0
Net cash used in financing activities (3,000) 0
Net increase in cash and cash equivalents 253,000 165,000
Cash and cash equivalents, beginning of period 179,000 18,000
Cash and cash equivalents, end of period 432,000 183,000
Supplemental disclosures of cash flow information:    
Cash paid for interest 5,000 5,000
Cash paid for income taxes 0 0
Noncash financing and investing activities:    
Fair value of common stock and warrants granted to settle accrued payroll and payroll taxes - related parties $ 462,000 $ 0